Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Telix Pharmaceuticals Limited
Q2 2024 Revenue and Business Highlights, Guidance Upgrade
July 17, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Telix Welcomes CMS Proposal to Improve Payment for Specialised Diagnostic Radiopharmaceuticals
July 10, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Telix Announces Launch of Proposed Initial Public Offering in the United States
June 05, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
June 02, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Telix Announces Positive rPFS Data from ProstACT SELECT Trial of TLX591 rADC Therapy Candidate in Prostate Cancer
May 30, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Telix Submits NDA for New Prostate Cancer Imaging Agent
May 28, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer
May 20, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Telix Files Registration Statement for Proposed Initial Public Offering in the United States
May 17, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Q1 2024 Revenue and Business Update
April 17, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation
April 15, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
QDOSE® Platform Partnership for Personalized Dosimetry in Radiopharmaceutical Therapy
March 18, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Appointment of Dr Darren Patti to Group Chief Operating Officer
March 11, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform
March 04, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
February 26, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline
February 22, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform
February 07, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Telix Highlights Presentations at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2024)
January 22, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Telix Announces Planned Registered Public Offering and Listing in the United States
January 04, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Telix to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
Telix to Collaborate With Kettering Health on Diagnostic PSMA Imaging & Targeting Theranostics
September 07, 2021
From
Telix Pharmaceuticals Limited
Via
Business Wire
Tickers
ASX:TLX
Telix Pharmaceuticals and Applied Radiology Launch TelixU Medical Education Platform Focused on Radiopharmaceutical Research
June 14, 2021
From
Telix Pharmaceuticals Limited
Via
Business Wire
Tickers
ASX:TLX
Telix Launches “Gallium Wave” Awareness Website
June 11, 2021
From
Telix Pharmaceuticals Limited
Via
Business Wire
Tickers
ASX:TLX
Cardinal Health and Telix Launch Gallium Awareness Campaign With Release of White-Paper: “Moving Beyond the Myth”
May 27, 2021
From
Telix Pharmaceuticals Limited
Via
Business Wire
Tickers
ASX:TLX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.